HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lee, W. Y. Articles by Sehon, A. H. Search for Related Content PubMed Articles by Lee, W. Y. Articles by Sehon, A. H.

Suppression of Reaginic Antibody Formation

I. Induction of Hapten-Specific Tolerance¹

From the MRC Group for Allergy, Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

Abstract

Reaginic antibodies to DNP and ovalbumin were induced readily in B₆D₂F₁ mice by a single intraperitoneal injection of 1 µg of DNP-ovalbumin suspended with 1 mg aluminum hydroxide in 0.5 ml of saline. The formation of anti-DNP reaginic antibody was completely suppressed by treatment of mice with a conjugate consisting of the hapten coupled to an isologous, nonimmunogenic carrier, viz., murine -globulins. However, this treatment did not affect the level of antibody formation to the carrier of the immunizing antigen. The induction of unresponsiveness was dose dependent, complete suppression being achieved with 1 mg of the tolerogen. The state of unresponsiveness could be maintained for prolonged periods (these observations were made over a period of at least 8 months) by repeated injections of the tolerogen at intervals of 2 months. More importantly, the state of unresponsiveness could be induced readily not only in normal, but also in sensitized mice, i.e., this treatment was capable of abrogating an ongoing reaginic response, and the suppression was immunologically specific. Hence this system appears to have a great potential for adaptation to the treatment of allergic diseases in man.

Footnotes

¹ This investigation was supported by grants from the Medical Research Council of Canada. The results of this study were presented at the 10th Symposium of the Collegium Internationale Allergologicum, Copenhagen, Denmark, August, 1974.

² Holder of a Scholarship from the Medical Research Council of Canada.